Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

New cohorts in PSC and PHSR arrive as the School launches curriculum updates and deepens its commitment to research and student success.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Russell Weiner, PhD, FAAPS, shares insights on preanalytics in biopharmaceutical research and offers workshops on career development.

Pharmaceutical scientist’s career blends metallobiochemistry and mentorship.

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.

Pharmaceutical scientist aims to foster continued collaborations and drive interdisciplinary research.

Read about the groundbreaking new program that is believed to be the first of its kind in the world in the latest issue of “CATALYST.”

The program has been instrumental in promoting the academic and professional success of students from historically underrepresented backgrounds in the schools of medicine and pharmacy.

Team approach is a win-win for researchers, patients.